The Meditech EBV EA+EBNA-1 IgA ELISA is an enzyme linked immunosorbent assay intended for the quantitative detection of human IgA antibodies to the early antigen and nuclear antigen of the Epstein-Barr virus contained in human serum or plasma. Results are obtained in 2 hours. These products are designed for differentiating nasopharyngeal carcinoma patients from normal population and suit for mass screening.
Features
- Use genetic engineered EBV-associated proteins as antigens.
- With greater than 95% of specificity and sensitivity.
- Easy in assay procedure and result interpretation.
- Quantitative results or qualitative with ISR.
- Suitable for early screen, diagnosis and prognosis of NPC.
Main Products
biotechnology clinical laboratory reagents